SWARTZ DAVID L
Transaction: 06/18/2026
SELL
Change
-2,699
Price
$53.89
Filing
06/22/2026
Type
SELL
RadNet, Inc.
RDNT • Medical - Diagnostics & Research
$69.65
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$5.59B
Growth
8.6%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive free cash flow · 1.14Healthy liquidity · 1.76Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$69.65
Change0.00%
Shares Out78.73M
Market Cap$5.59B
Enterprise Value$7.05B
52W Range50.82 - 85.84
Beta1.38
P/E-264.72
P/S2.46
P/B5.10
P/FCF-85.46
EV/Sales3.11
Price$69.65
Change0.00%
Shares Out78.73M
Market Cap$5.59B
Enterprise Value$7.05B
52W Range50.82 - 85.84
Beta1.38
P/E-264.72
P/S2.46
P/B5.10
P/FCF-85.46
EV/Sales3.11
EV/EBITDA20.97
EV/FCF-107.73
Earnings Yield-0.38%
FCF Yield-1.17%
Dividend Yield0.00%
Gross Margin4.45%
Oper. Margin4.45%
Profit Margin-0.91%
Debt/Eq1.71
Current Ratio1.76
Quick Ratio1.76
Revenue 5Y8.63%
FCF 5Y2.37%
Target$78.00
Target Upside11.99%
Target Median$78.00
Target Range65.00 - 91.00
Volume709.21K
Avg Volume852.74K
EPS Surprise-0.14
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
68/100
Price Attractiveness
Cheap or expensive today
47/100
Why this score▼
Positive free cash flow · 1.14Healthy liquidity · 1.76Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$65.00
Mean
$78.00
Median
$78.00
High
$91.00
Insider Transactions
Recent executive and insider activity
Berger Howard G
Transaction: 06/16/2026
SELL
Change
-90
Price
Not reported
Filing
06/18/2026
Type
SELL
Wesdorp Cornelis
Transaction: 06/16/2026
SELL
Change
-4,750
Price
$58.11
Filing
06/18/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| SWARTZ DAVID L | SELL | -2,699 | $53.89 | 06/18/2026 | 06/22/2026 |
| Berger Howard G | SELL | -90 | Not reported | 06/16/2026 | 06/18/2026 |
| Wesdorp Cornelis | SELL | -4,750 | $58.11 | 06/16/2026 | 06/18/2026 |
| Forthuber Stephen M | SELL | -19,853 | $58.61 | 06/15/2026 | 06/16/2026 |
| Levitt Lawrence L | BUY | +2,946 | Not reported | 06/02/2026 | 06/03/2026 |
| Jacobs Laura Pastre | BUY | +2,946 | Not reported | 06/02/2026 | 06/03/2026 |
| SPURLOCK GREGORY E. | BUY | +2,946 | Not reported | 06/02/2026 | 06/03/2026 |
| SWARTZ DAVID L | BUY | +2,946 | Not reported | 06/02/2026 | 06/03/2026 |
| Berger Howard G | SELL | -25,992 | $18.64 | 05/05/2026 | 05/06/2026 |
| Berger Howard G | BUY | +25,992 | $18.64 | 05/05/2026 | 05/06/2026 |
| Sorensen Alma Gregory | SELL | -7,000 | Not reported | 03/19/2026 | 03/23/2026 |
| Sorensen Alma Gregory | SELL | -800 | $62.72 | 03/18/2026 | 03/18/2026 |
| Sorensen Alma Gregory | SELL | -5,919 | $61.72 | 03/16/2026 | 03/18/2026 |
| Sorensen Alma Gregory | SELL | -16,831 | Not reported | 03/10/2026 | 03/12/2026 |
| Sorensen Alma Gregory | BUY | +3,742 | Not reported | 03/10/2026 | 03/12/2026 |
| Sorensen Alma Gregory | BUY | +16,533 | Not reported | 03/03/2026 | 03/05/2026 |
| Murdock Michael N | BUY | +6,613 | Not reported | 03/03/2026 | 03/05/2026 |
| Berger Howard G | BUY | +124,001 | Not reported | 03/03/2026 | 03/05/2026 |
| HAMES NORMAN R | BUY | +3,100 | Not reported | 03/03/2026 | 03/05/2026 |
| Forthuber Stephen M | BUY | +22,045 | Not reported | 03/03/2026 | 03/05/2026 |